查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2081880

局部用藥市場：2026-2032年全球市場預測（依產品類型、給藥技術、給藥途徑、製劑類型、治療應用、最終用戶及分銷管道分類）

Topical Drug Delivery Market by Product Type, Delivery Technology, Route of Administration, Formulation Type, Therapeutic Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，局部用藥市場規模將達到 3,221.3 億美元，年複合成長率為 7.29%。

主要市場統計數據
基準年 2025 1967.6億美元
預計年份：2026年 2104.1億美元
預測年份：2032年 3221.3億美元
複合年成長率 (%) 7.29%

局部用藥市場概覽

隨著局部治療、提高遵守用藥以及避免全身性用藥的替代療法在醫療保健領域日益重要，外用藥物市場正在不斷擴大。乳膏、凝膠、軟膏、泡沫劑、噴霧劑、經皮貼片、藥用繃帶和成膜OK繃外用製劑在皮膚病學、疼痛管理、荷爾蒙療法、創傷護理、抗感染以及某些循環系統和神經系統疾病的治療中繼續發揮核心作用。

局部用藥市場發生變革性變化

三大協同變革正在重塑競爭格局：精準皮膚病學、監管現代化和基於平台的製劑科學。美國FDA和歐洲藥品管理局（EMA）等監管機構正在提高對局部用藥產品的品質、體外釋放研究、體外滲透性研究以及生物等效性證據的要求，尤其針對複雜的學名藥和局部產品。

人工智慧在局部用藥領域的累積影響

人工智慧正對藥物遞送研發的整個領域產生累積影響，從輔料篩檢和分子溶解度預測到皮膚滲透性建模、穩定性評估和臨床試驗最佳化，無一例外。機器學習模型有助於縮小配方變數範圍、預測相容性風險並支持品質源自於設計 (QbD) 工作流程，從而減少對純粹啟發式開發的依賴。

局部用藥遞送的關鍵區域見解

由於醫療保健覆蓋範圍的擴大、強大的學名藥生產能力、皮膚科領域日益成長的需求，以及中國、印度、日本、韓國、澳大利亞和東協市場臨床研究活動的活性化，亞太地區正經皮。北美地區憑藉FDA的產品指南、完善的臨床研究基礎設施、皮膚科領域較高的處方箋滲透率，以及經皮療法在疼痛管理、荷爾蒙補充療法和慢性病管理方面的成熟應用，繼續保持著創新和商業化的重要中心地位。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

隨著區域監管合作的加強，以及製造商在快速都市化的醫療保健體系中拓展皮膚病學、疼痛管理、抗感染疾病和創傷護理產品的供應管道，東協市場的重要性日益凸顯。在海灣合作理事會（GCC）國家，專業醫療保健基礎設施正在不斷完善，高品質的進口產品和本地註冊的局部用藥更受青睞，尤其是在皮膚科診所、醫院和零售藥局，這得益於私人醫療保健的擴張。

局部用藥遞送的關鍵國家見解

美國憑藉其成熟的處方箋皮膚病醫療保健體系、FDA對複雜學名藥的指導、積極的臨床試驗以及強大的專科藥房生態系統，在藥物輸送技術創新方面處於領先地位。加拿大透過規範的准入、公私合營的報銷模式以及完善的皮膚病醫療保健路徑來支持市場需求。同時，墨西哥和巴西也因其大都會圈、不斷擴張的零售藥房網路以及對價格合理的皮膚病、疼痛和創傷護理外用藥物的需求，看到了新的商機。

為行業領導者提供的實用建議

產業供應商應優先考慮可重複使用的製劑平台，這些平台適用於多種分子和適應症，包括半固體製劑、成膜技術、微針、脂質奈米顆粒、奈米乳劑和基於聚合物的緩釋製劑。儘早投資於體外釋放試驗、體外滲透試驗、皮膚刺激性和致敏性試驗、穩定性研究以及人體因素檢驗，將有助於降低研發風險，並增強監管機構的信心。

調查方法

本執行摘要基於系統的二手研究方法，利用公開可用和行業認可的來源，包括美國 FDA、EMA 和國家衛生機構的監管指南、藥典標準、同行評審的皮膚病學和藥學文獻、臨床實驗室研究途徑資訊來源、專利資料庫以及聯合國、世界銀行、經合組織和世界衛生組織等組織提供的宏觀經濟和人口統計資料。

結論

藥物遞送方式正從傳統的局部用藥轉向以病人為中心的高階治療平台。這項轉變的促進因素包括：對更安全的局部給藥方式的需求（包括慢性病管理）、皮膚科領域的需求、人口老化、門診治療、提高遵守用藥以及減少全身暴露。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 局部用藥市場：依產品類型分類

  • 奶油
    • 水毛油
    • 油水
  • 凝膠
    • 水凝膠
    • 有機凝膠
  • 軟膏
    • 親水性
    • 親油性
  • 修補
    • 多層
    • 單層

第8章 局部用藥市場：依給藥技術分類

  • 主動交付
  • 被動式遞送

第9章 局部用藥市場：依給藥途徑分類

  • 頰黏膜
  • 經皮
  • 鼻內
  • 眼科
  • 直腸
  • 陰道

第10章 局部用藥市場：依劑型類型分類

  • 液體
  • 半固態製劑
  • 固態劑型
  • 噴霧和泡沫

第11章 局部用藥市場：依治療應用分類

  • 皮膚科
    • 抗菌
    • 抗真菌劑
    • 抗發炎藥
  • 荷爾蒙補充療法
    • 雌激素
    • 睪固酮
  • 疼痛管理
    • 局部麻醉劑
    • NSAIDs

第12章 局部用藥市場：依最終用戶分類

  • 診所
  • 居家醫療
  • 醫院
    • 住院治療
    • 門診
  • 零售藥房

第13章 局部用藥市場：依通路分類

  • 離線
    • 醫院藥房
    • 零售藥房
  • 網路藥房

第14章 局部用藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 局部用藥市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 局部用藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • 3M Company
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Crescita Therapeutics Inc.
  • DuPont de Nemours, Inc.
  • Element Materials Technology
  • Galderma SA
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Johnson & Johnson Services, Inc.
  • Kindeva Drug Delivery LP
  • LEO Pharma A/S
  • Lubrizol Corporation
  • MedPharm Group Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Porex Corporation
  • Sun Pharmaceutical Industries Ltd.
Product Code: MRR-4316E4E89103

The Topical Drug Delivery Market is projected to grow by USD 322.13 billion at a CAGR of 7.29% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 196.76 billion
Estimated Year [2026] USD 210.41 billion
Forecast Year [2032] USD 322.13 billion
CAGR (%) 7.29%

Topical Drug Delivery Market Introduction

The topical drug delivery landscape is expanding as healthcare systems prioritize localized therapy, improved adherence, and alternatives to systemic exposure. Topical formulations, including creams, gels, ointments, foams, sprays, transdermal patches, medicated plasters, and film-forming systems, remain central to dermatology, pain management, hormone therapy, wound care, anti-infectives, and selected cardiovascular and neurologic indications.

Demand is supported by measurable demographic and clinical trends, including population aging reported by the United Nations, the high global burden of skin and subcutaneous diseases documented in Global Burden of Disease research, and rising use of outpatient and home-based care. For manufacturers, the market is moving from conventional semisolids toward advanced topical drug delivery systems that combine penetration enhancers, controlled-release polymers, nanocarriers, microneedles, and patient-friendly applicators to improve bioavailability, dosing consistency, and therapeutic adherence.

Transformative Shifts in the Topical Drug Delivery Landscape

The competitive landscape is being reshaped by three converging shifts: precision dermatology, regulatory modernization, and platform-based formulation science. Regulators such as the U.S. FDA and European Medicines Agency have increased expectations for topical product quality, in vitro release testing, in vitro permeation testing, and bioequivalence evidence, especially for complex generics and locally acting products.

At the same time, pharmaceutical developers are prioritizing lifecycle management through reformulations that improve skin feel, dosing convenience, stability, and adherence. Device-enabled delivery, including metered-dose topical systems and transdermal patches, is creating differentiation beyond the active pharmaceutical ingredient. The shift from product-only strategies to formulation-platform strategies is becoming a decisive factor for topical drug delivery companies seeking faster development cycles, stronger regulatory packages, and more defensible portfolios.

Cumulative Impact of Artificial Intelligence on Topical Drug Delivery

Artificial intelligence is becoming a cumulative force across topical drug delivery R&D, from excipient screening and molecule-solubility prediction to skin permeation modeling, stability assessment, and clinical trial optimization. Machine learning models can help narrow formulation variables, predict compatibility risks, and support quality-by-design workflows, reducing reliance on purely empirical development.

AI is also improving commercial execution. Digital dermatology tools, image-based lesion tracking, real-world adherence analytics, and pharmacovigilance signal detection can help align topical therapies with patient behavior and physician decision-making. While AI does not replace validated laboratory testing, clinical evidence, or regulatory review, it strengthens development productivity and accelerates insight generation when paired with controlled datasets, standardized skin models, validated endpoints, and compliant data governance.

Key Regional Insights for Topical Drug Delivery

Asia-Pacific is becoming a high-priority region for topical drug delivery due to expanding healthcare access, strong generic manufacturing capacity, rising dermatology demand, and growing clinical research activity across China, India, Japan, South Korea, Australia, and ASEAN markets. North America remains a major innovation and commercialization hub, supported by FDA product-specific guidance, advanced clinical research infrastructure, high prescription dermatology adoption, and established use of transdermal therapies for pain, hormone replacement, and chronic disease management.

Europe benefits from established pharmaceutical regulation, strong dermatology research, mature pharmacovigilance systems, and demand for evidence-based treatment across the European Union and the United Kingdom. Latin America shows increasing demand for affordable topical generics and branded dermatology products, with Brazil and Mexico serving as regional anchors due to large patient populations and retail pharmacy reach. The Middle East is investing in specialty care, private healthcare expansion, and hospital infrastructure, while Africa's opportunity is linked to essential medicines access, infectious skin disease management, wound care needs, and scalable low-cost topical therapies suited to diverse healthcare settings.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are gaining relevance as regional regulatory cooperation improves and manufacturers expand access to dermatology, pain, anti-infective, and wound-care products across fast-urbanizing healthcare systems. GCC countries are strengthening specialty healthcare infrastructure and favor high-quality imported and locally registered topical therapies, particularly in dermatology clinics, hospitals, and retail pharmacy channels supported by expanding private care.

The European Union remains influential because its regulatory standards shape global expectations for topical product quality, safety, bioequivalence, pharmacovigilance, and post-authorization monitoring. BRICS countries provide a powerful mix of manufacturing scale, large patient populations, public health programs, and government interest in affordable medicines, making them important for both supply and demand. G7 economies lead in advanced formulation science, intellectual property creation, clinical evidence generation, and reimbursement scrutiny, while NATO member markets overlap with many high-income healthcare systems that prioritize resilient pharmaceutical supply chains, regulated cross-border procurement, and secure access to essential medicines.

Key Country Insights in Topical Drug Delivery

The United States leads in topical drug delivery innovation because of its mature prescription dermatology environment, FDA guidance for complex topical generics, high clinical trial activity, and strong specialty pharmacy ecosystem. Canada supports demand through regulated access, public-private reimbursement models, and established dermatology care pathways, while Mexico and Brazil offer opportunities through large urban populations, expanding retail pharmacy networks, and demand for affordable topical medicines for skin disease, pain, and wound care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain provide established dermatology care pathways, high regulatory expectations, and strong adoption of evidence-based prescription therapies, while Russia remains a sizable market with localized registration, reimbursement, and supply considerations. China and India are central to scale, with China advancing regulatory reform and domestic innovation, and India leveraging global generic manufacturing strength, cost-efficient development, and broad access to topical medicines. Japan, Australia, and South Korea contribute through high clinical standards, aging populations, advanced healthcare infrastructure, and adoption of innovative dermatology and transdermal products.

Actionable Recommendations for Industry Leaders

Industry vendors should prioritize formulation platforms that can be reused across multiple molecules and indications, including semisolid systems, film-forming technologies, microneedles, liposomes, nanoemulsions, and polymer-based controlled-release approaches. Early investment in in vitro release testing, in vitro permeation testing, skin irritation and sensitization studies, stability programs, and human factor validation can reduce development risk and support regulatory confidence.

Organizations should also build AI-enabled formulation databases, diversify excipient and packaging suppliers, and align commercial strategies with regional reimbursement, prescribing behavior, climate-related stability requirements, and pharmacy channel dynamics. Partnerships with dermatology networks, contract development and manufacturing organizations, academic laboratories, and digital health providers can improve clinical evidence generation, patient adherence, lifecycle management, and market access for differentiated topical drug delivery products.

Research Methodology

This executive summary is based on a structured secondary research approach using publicly available and industry-recognized sources, including regulatory guidance from the U.S. FDA, EMA, national health agencies, pharmacopeial standards, peer-reviewed dermatology and pharmaceutical sciences literature, clinical trial registries, patent databases, and macroeconomic and demographic datasets from institutions such as the United Nations, World Bank, OECD, and WHO.

Insights were validated through triangulation across regulatory trends, technology adoption, therapeutic demand, manufacturing capabilities, healthcare access indicators, and regional policy signals. The analysis emphasizes verified qualitative and quantitative evidence rather than unsupported market claims, ensuring that conclusions remain suitable for strategic planning, SEO-focused industry communication, and evidence-based executive decision-making.

Conclusion

Topical drug delivery is transitioning from conventional skin-applied dosage forms to advanced, patient-centered therapeutic platforms. Momentum is supported by chronic disease management, dermatology demand, aging populations, outpatient care, and the need for safer localized delivery with improved adherence and reduced systemic exposure.

The strongest opportunities will emerge for organizations that integrate formulation science, regulatory evidence, AI-enabled development, robust quality systems, and regional access strategies. Stakeholders that can combine clinical credibility with scalable manufacturing, supply-chain resilience, and differentiated user experience will be best positioned to compete in the evolving topical drug delivery market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Topical Drug Delivery Market, by Product Type

  • 7.1. Creams
    • 7.1.1. Oil In Water
    • 7.1.2. Water In Oil
  • 7.2. Gels
    • 7.2.1. Hydrogel
    • 7.2.2. Organogel
  • 7.3. Ointments
    • 7.3.1. Hydrophilic
    • 7.3.2. Lipophilic
  • 7.4. Patches
    • 7.4.1. Multi Layer
    • 7.4.2. Single Layer

8. Topical Drug Delivery Market, by Delivery Technology

  • 8.1. Active Delivery
  • 8.2. Passive Delivery

9. Topical Drug Delivery Market, by Route of Administration

  • 9.1. Buccal
  • 9.2. Dermal
  • 9.3. Nasal
  • 9.4. Ocular
  • 9.5. Rectal
  • 9.6. Vaginal

10. Topical Drug Delivery Market, by Formulation Type

  • 10.1. Liquids
  • 10.2. Semi-solids
  • 10.3. Solids
  • 10.4. Sprays & Foams

11. Topical Drug Delivery Market, by Therapeutic Application

  • 11.1. Dermatology
    • 11.1.1. Anti Bacterial
    • 11.1.2. Anti Fungal
    • 11.1.3. Anti Inflammatory
  • 11.2. Hormone Replacement
    • 11.2.1. Estrogen
    • 11.2.2. Testosterone
  • 11.3. Pain Management
    • 11.3.1. Local Anesthetics
    • 11.3.2. NSAIDs

12. Topical Drug Delivery Market, by End User

  • 12.1. Clinics
  • 12.2. Home Healthcare
  • 12.3. Hospitals
    • 12.3.1. Inpatient
    • 12.3.2. Outpatient
  • 12.4. Retail Pharmacies

13. Topical Drug Delivery Market, by Distribution Channel

  • 13.1. Offline
    • 13.1.1. Hospital Pharmacy
    • 13.1.2. Retail Pharmacy
  • 13.2. Online Pharmacies

14. Topical Drug Delivery Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Topical Drug Delivery Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Topical Drug Delivery Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. 3M Company
  • 18.2. AbbVie Inc.
  • 18.3. Bausch Health Companies Inc.
  • 18.4. Bayer AG
  • 18.5. Crescita Therapeutics Inc.
  • 18.6. DuPont de Nemours, Inc.
  • 18.7. Element Materials Technology
  • 18.8. Galderma SA
  • 18.9. GlaxoSmithKline plc
  • 18.10. Hisamitsu Pharmaceutical Co.,Inc.
  • 18.11. Johnson & Johnson Services, Inc.
  • 18.12. Kindeva Drug Delivery L.P.
  • 18.13. LEO Pharma A/S
  • 18.14. Lubrizol Corporation
  • 18.15. MedPharm Group Ltd.
  • 18.16. Merck & Co., Inc.
  • 18.17. Novartis AG
  • 18.18. Pfizer Inc.
  • 18.19. Porex Corporation
  • 18.20. Sun Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TOPICAL DRUG DELIVERY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CREAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OIL IN WATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OIL IN WATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OIL IN WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WATER IN OIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WATER IN OIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WATER IN OIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HYDROGEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HYDROGEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HYDROGEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ORGANOGEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ORGANOGEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ORGANOGEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HYDROPHILIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HYDROPHILIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HYDROPHILIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LIPOPHILIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIPOPHILIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIPOPHILIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MULTI LAYER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MULTI LAYER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MULTI LAYER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE LAYER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE LAYER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE LAYER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ACTIVE DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ACTIVE DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ACTIVE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PASSIVE DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PASSIVE DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PASSIVE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BUCCAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BUCCAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BUCCAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DERMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DERMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DERMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NASAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NASAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NASAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RECTAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RECTAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RECTAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VAGINAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VAGINAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VAGINAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LIQUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LIQUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SEMI-SOLIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SEMI-SOLIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SEMI-SOLIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SOLIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SOLIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SOLIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SPRAYS & FOAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPRAYS & FOAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SPRAYS & FOAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DERMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANTI BACTERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTI BACTERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANTI BACTERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTI FUNGAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANTI FUNGAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTI FUNGAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANTI INFLAMMATORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTI INFLAMMATORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANTI INFLAMMATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HORMONE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HORMONE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HORMONE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ESTROGEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ESTROGEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ESTROGEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TESTOSTERONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TESTOSTERONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TESTOSTERONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NSAIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NSAIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NSAIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 265. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 266. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 267. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 268. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 270. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 274. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 275. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 277. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 313. G7 TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 316. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 317. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 318. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 319. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 321. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 324. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 325. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 326. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 328. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 329. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 330. NATO TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 331. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 333. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 334. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 335. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 336. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 337. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 338. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 340. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 341. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 342. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 343. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 345. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 346. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 347. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 359. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 360. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 361. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 362. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 363. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 364. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 365. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 366. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 367. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2018-2032 (USD MILLION)
  • TABLE 368. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2018-2032 (